» Articles » PMID: 19638322

Induction of Cellular and Humoral Responses by Autoclaved and Heat-killed Antigen of Leishmania Donovani in Experimental Visceral Leishmaniasis

Overview
Journal Parasitol Int
Publisher Elsevier
Specialty Parasitology
Date 2009 Jul 30
PMID 19638322
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The potential of autoclaved and heat-killed antigen of Leishmania donovani to induce cell-mediated and humoral response has been evaluated in the present study. The vaccines were delivered thrice subcutaneously at an interval of 2 weeks. Two weeks after second booster, BALB/c mice were challenged with 10(7) stationary phase promastigotes of L. donovani. Significant protection was achieved in immunized mice against L. donovani challenge with 69% to 76% and 59% to 64% reduction in parasite load in the liver and spleen respectively. Immunization induced significantly higher level of delayed type hypersensitivity (DTH) response in mice immunized with heat-killed antigen followed by autoclaved antigen. The immune response was assessed by quantifying Leishmania-specific antibodies and cytokine production. The antibody response was predominantly of IgG type with increased IgG2a production and lesser amount of IgM. The immunization preferentially stimulates the production of IFN-gamma and IL-2 in splenocytes which suggests a Th1 type response with a concomitant down-regulation of IL-10 and IL-4. These results indicate a potential for the heat-killed and autoclaved antigen as a vaccine which could trigger cell-mediated immune response.

Citing Articles

Prophylactic antineoplastic activity of Toxoplasma gondii RH derived antigen against ehrlich solid carcinoma with evidence of shared antigens by comparative immunoblotting.

Eissa M, Gaafar M, Younis L, Ismail C, El Skhawy N Infect Agent Cancer. 2023; 18(1):21.

PMID: 37029378 PMC: 10082516. DOI: 10.1186/s13027-023-00500-3.


The host micro-RNA cfa-miR-346 is induced in canine leishmaniasis.

Buffi G, Diotallevi A, Ceccarelli M, Bruno F, Castelli G, Vitale F BMC Vet Res. 2022; 18(1):247.

PMID: 35761326 PMC: 9235276. DOI: 10.1186/s12917-022-03359-5.


Evaluation of different total Leishmania amazonensis antigens for the development of a first-generation vaccine formulated with a Toll-like receptor-3 agonist to prevent cutaneous leishmaniasis.

Germano M, Lozano E, Sanchez M, Bruna F, Garcia-Bustos M, Sosa Lochedino A Mem Inst Oswaldo Cruz. 2020; 115:e200067.

PMID: 32667458 PMC: 7357544. DOI: 10.1590/0074-02760200067.


Assessment of the Effects of a Novel Herbal Immunomodulator Drug (IMOD) on Cytokine Profiles in Experimental Canine Visceral Leishmaniasis: a Preliminary Survey.

Malmasi A, Ziaie Ardestani B, Bayanolhagh S, Mohebali M, Khorram Khorshid H, Sadrpour P Iran J Parasitol. 2015; 9(3):292-301.

PMID: 25678912 PMC: 4316559.


Protective immunity using MPL-A and autoclaved Leishmania donovani as adjuvants along with a cocktail vaccine in murine model of visceral leishmaniasis.

Kaur T, Thakur A, Kaur S J Parasit Dis. 2014; 37(2):231-9.

PMID: 24431576 PMC: 3793088. DOI: 10.1007/s12639-012-0171-7.